| NAME OF THE PROJECT | : Carbamazepine |
| PRODUCT NAME | : Carbamazepine USP Related Compound - C |
| CODE & CAT NO | : LP - 4260-03-004 |
| MOLECULAR FORMULA | : C16H13N3O2 |
| MOLECULAR WEIGHT | :279.29 |
| CAS NO | : 1219170-51-0 |
| CHEMICAL NAME | : (5H-dibenzo[b,f]azepin-5-ylcarbonyl)urea (N-carbamoylcarbamazepine) |
| CAT NO | : LP - 4260-01-001 |
| CAS NO | : 298-46-4 |
| Mol.F | : C15H12N2O |
| Mol.Wt. | : 236.27 |
| CAT NO | : LP - 4260-03-002 |
| CAS NO | : 3564-73-6 |
| Mol.F | : C15H14N2O |
| Mol.Wt. | : 238.28 |
| CAT NO | : LP - 4260-03-002 |
| CAS NO | : 3564-73-6 |
| Mol.F | : C15H14N2O |
| Mol.Wt. | : 238.28 |
| CAT NO | : LP - 4260-03-002 |
| CAS NO | : 3564-73-6 |
| Mol.F | : C15H14N2O |
| Mol.Wt. | : 238.28 |
| CAT NO | : LP - 4260-03-002 |
| CAS NO | : 3564-73-6 |
| Mol.F | : C15H14N2O |
| Mol.Wt. | : 238.28 |
| CAT NO | : LP - 4260-03-002 |
| CAS NO | : 3564-73-6 |
| Mol.F | : C15H14N2O |
| Mol.Wt. | : 238.28 |
| CAT NO | : LP - 4260-03-002 |
| CAS NO | : 3564-73-6 |
| Mol.F | : C15H14N2O |
| Mol.Wt. | : 238.28 |
| CAT NO | : LP - 4260-03-002 |
| CAS NO | : 3564-73-6 |
| Mol.F | : C15H14N2O |
| Mol.Wt. | : 238.28 |
| CAT NO | : LP - 4260-03-002 |
| CAS NO | : 3564-73-6 |
| Mol.F | : C15H14N2O |
| Mol.Wt. | : 238.28 |
| CAT NO | : LP-4260-03-002 |
| CAS NO | : 3564-73-6 |
| Mol.F | : C15H14N2O |
| Mol.Wt. | : 238.28 |
| CAT NO | : LP - 4260-03-002 |
| CAS NO | : 3564-73-6 |
| Mol.F | : C15H14N2O |
| Mol.Wt. | : 238.28 |
| CAT NO | : LP - 4260-03-002 |
| CAS NO | : 3564-73-6 |
| Mol.F | : C15H14N2O |
| Mol.Wt. | : 238.28 |
CATEGORY : Carbamazepine
TOTAL PRODUCTS :12
FILTER BY : API
Lavybens pharma's competitive advanced manufacturing facilities, R & D capabilities, extensive domestic network in Indian Pharma market and International.
Copyrights © Lavybens Pharma All rights Reserved
